| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10004783 | HBV | ENSG00000116329.12 | protein_coding | OPRD1 | No | No | 4985 | P41143 |
| TVIS30074531 | HIV | ENSG00000116329.12 | protein_coding | OPRD1 | No | No | 4985 | P41143 |
| TVIS30022908 | HIV | ENSG00000116329.12 | protein_coding | OPRD1 | No | No | 4985 | P41143 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | OPRD1 |
|---|---|
| DrugBank ID | DB01192 |
| Drug Name | Oxymorphone |
| Target ID | BE0000420 |
| UniProt ID | P41143 |
| Regulation Type | antagonist |
| PubMed IDs | 17595308; 14998329 |
| Citations | Chamberlin KW, Cottle M, Neville R, Tan J: Oral oxymorphone for pain management. Ann Pharmacother. 2007 Jul;41(7):1144-52. Epub 2007 Jun 26.@@Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ: Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]. J Med Chem. 2004 Mar 11;47(6):1400-12. |
| Groups | Approved; Investigational; Vet_approved |
| Direct Classification | Phenanthrenes and derivatives |
| SMILES | [H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O |
| Pathways | Oxymorphone Action Pathway |
| PharmGKB | PA450748 |
| ChEMBL | CHEMBL963 |
